PATENT CLAIM ANALYSIS

Application Number: 15877349
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "136100"]

Abstract:
Isolated monoclonal antibodies that bind to specific epitopes of human tissue factor pathway inhibitor (TFPI) and the isolated nucleic acid molecules encoding them are provided. Pharmaceutical compositions comprising the anti-TFPI monoclonal antibodies and methods of treating deficiencies or defects in coagulation by administration of the antibodies are also provided.

Claim (Index 7):
The isolated monoclonal antibody of  claim 6 , wherein said epitope further comprises one or more residues selected from the group consisting of Glu100, Glu101, Asp102, Pro103, Gly104, Ile105, Cys106, Arg107, Gly108, Tyr109, Lys126, Gly128, Gly129, Cys130, Leu131, Gly132, and Asn133 of SEQ ID NO:1.

Metadata:
- Claim Count in Document: 40.0
- Percentile: 86.0
- Lexical Diversity: 1.2619
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13721755', '13721802', '13140296', '14775108', '13323691']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8218108542953981
- 35 USC 102 Novelty (BERT): 0.5585754517555573
- Combined Prediction Score: 0.795487314041414
- Mean Citation Score: 450.195104
- Max Citation Score: 476.53546
- Similarity Product: 330.879671892848

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test